Wellington Management Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $778K | Sell |
86,778
-4,570
| -5% | -$40.9K | ﹤0.01% | 1741 |
|
2025
Q1 | $685K | Buy |
91,348
+2,291
| +3% | +$17.2K | ﹤0.01% | 1773 |
|
2024
Q4 | $670K | Sell |
89,057
-18,763
| -17% | -$141K | ﹤0.01% | 1769 |
|
2024
Q3 | $819K | Buy |
+107,820
| New | +$819K | ﹤0.01% | 1730 |
|
2020
Q1 | – | Sell |
-22,708
| Closed | -$78K | – | 1915 |
|
2019
Q4 | $78K | Sell |
22,708
-5,420
| -19% | -$18.6K | ﹤0.01% | 1997 |
|
2019
Q3 | $80K | Sell |
28,128
-6,890
| -20% | -$19.6K | ﹤0.01% | 2008 |
|
2019
Q2 | $133K | Hold |
35,018
| – | – | ﹤0.01% | 2028 |
|
2019
Q1 | $285K | Buy |
+35,018
| New | +$285K | ﹤0.01% | 1969 |
|
2017
Q2 | – | Sell |
-202,317
| Closed | -$1.7M | – | 2161 |
|
2017
Q1 | $1.7M | Buy |
+202,317
| New | +$1.7M | ﹤0.01% | 1774 |
|
2016
Q3 | – | Sell |
-256,120
| Closed | -$727K | – | 2160 |
|
2016
Q2 | $727K | Sell |
256,120
-1,240,739
| -83% | -$3.52M | ﹤0.01% | 1835 |
|
2016
Q1 | $4.24M | Sell |
1,496,859
-5,973,580
| -80% | -$16.9M | ﹤0.01% | 1401 |
|
2015
Q4 | $77.1M | Sell |
7,470,439
-31,497
| -0.4% | -$325K | 0.02% | 550 |
|
2015
Q3 | $85.5M | Buy |
7,501,936
+520,365
| +7% | +$5.93M | 0.02% | 491 |
|
2015
Q2 | $104M | Sell |
6,981,571
-38,712
| -0.6% | -$578K | 0.03% | 477 |
|
2015
Q1 | $63.4M | Sell |
7,020,283
-368,990
| -5% | -$3.33M | 0.02% | 662 |
|
2014
Q4 | $89.9M | Buy |
7,389,273
+1,529,847
| +26% | +$18.6M | 0.02% | 548 |
|
2014
Q3 | $57.3M | Buy |
5,859,426
+510,081
| +10% | +$4.99M | 0.02% | 674 |
|
2014
Q2 | $68.2M | Buy |
5,349,345
+1,329,584
| +33% | +$17M | 0.02% | 642 |
|
2014
Q1 | $42.5M | Sell |
4,019,761
-771,469
| -16% | -$8.16M | 0.01% | 795 |
|
2013
Q4 | $36.4M | Buy |
4,791,230
+2,159,640
| +82% | +$16.4M | 0.01% | 827 |
|
2013
Q3 | $19.2M | Buy |
+2,631,590
| New | +$19.2M | 0.01% | 1014 |
|